Adult cancer survivors continue to face variety of unmet needs years after treatment
the ONA take:
Adult cancer survivors continue to face a variety of unmet needs years after treatment, including anxiety and chronic pain, according to a recent study published in Cancer.
Researchers at The University of Texas at Arlington and the University of Central Florida conducted a survey of 1,514 cancer survivors who were aged 18 or older. These patients were randomly chosen from population-based cancer registries across 14 states and included cancer survivors of the breast, prostate, colon, skin, bladder and uterus.
In an open-ended questionnaire, they were asked to divulge any needs that were not satisfied as cancer survivors.
After a six-person interdisciplinary team analyzed the answers and coded them into 16 themes, they found that the average number of unmet needs per survivor was 2.88, with breast cancer survivors identifying the most. Thirty-eight percent of survivors said they faced physical problems, making it the most common issue.
The team found that personal control, which was not previously identified in the literature of unmet needs and included the ability to make decisions regarding one’s own healthcare status as well as discuss cancer with one’s employer, was also dominant.
While the average number of needs decreased with age, they did not differ significantly based on gender. However, more male patients identified problems related to physical needs and personal control.
Adult cancer survivors continue to face a variety of unmet needs years after treatment, including anxiety and chronic pain.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|